journal article·2025-01-14

Patterned Antigens on DNA Origami Controls the Structure and Cellular Uptake of Immune Complexes

Travis R. Douglas, Shana Alexander, Leo Y. T. Chou

ACS Nano· Volume 19· Issue 1
Publisher page

Abstract

Immune complexes (ICs), formed via antibody (Ab)-antigen (Ag) binding, trigger diverse immune responses, which are critical for natural immunity and have uses for vaccines and immunotherapies. While IC-elicited immune responses depend on its structure, existing methods for IC synthesis produce heterogeneous assemblies, which limits control over their cellular interactions and pharmacokinetics. In this study, we demonstrate the use of DNA origami to create synthetic ICs with defined shape, size, and solubility by displaying Ags in prescribed spatial patterns. We find that Ag arrangement relative to the spatial tolerance of IgG Fab arms (∼13-18 nm) determines IC formation into "monomeric" versus "multimeric" regimes. When Ag spacing matches Fab arm tolerance, ICs are exclusively monomeric, while spacing mismatches favor the formation of multimeric ICs. Within each IC regime, parameters such as the number of Ags and Ab-Ag ratios, as well as DNA origami shape, further fine-tune IC size, shape, and Fc valency. These parameters influenced IC interactions with FcγR-expressing immune cells, with uptake by macrophages showing greater sensitivity to IC cross-linking while dendritic cells were more responsive to Ab valency. Our findings thus provide design principles for controlling the structure and cellular interactions of synthetic ICs and highlight DNA origami-scaffolded ICs as a programmable platform for investigating IC immunology and developing FcγR-targeted therapeutics and vaccines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Monoclonal and Polyclonal Antibodies Research · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biomedical Engineering, University of Toronto, Toronto M5S 2E3, Canada

Funding

Canada Foundation for Innovation · Natural Sciences and Engineering Research Council of Canada

References (100+)

Show source-provided references
1. 10.1038/nri220610.1038/nri2206 ↗
2. 10.1016/S0065-2776(07)96005-810.1016/S0065-2776(07)96005-8 ↗
3. 10.1016/B978-0-323-95895-0.00005-210.1016/B978-0-323-95895-0.00005-2 ↗
4. 10.1111/imr.1235010.1111/imr.12350 ↗
5. 10.4049/jimmunol.141.6.185510.4049/jimmunol.141.6.1855 ↗
6. 10.1038/nri358210.1038/nri3582 ↗
7. 10.1016/S1074-7613(02)00294-710.1016/S1074-7613(02)00294-7 ↗
8. 10.1128/9781555819194.ch2210.1128/9781555819194.ch22 ↗
9. 10.1038/ni.293910.1038/ni.2939 ↗
10. 10.1111/imr.1234310.1111/imr.12343 ↗
11. 10.7554/eLife.6831110.7554/eLife.68311 ↗
12. 10.4049/jimmunol.175.7.445010.4049/jimmunol.175.7.4450 ↗
13. 10.1016/j.cell.2018.05.05910.1016/j.cell.2018.05.059 ↗
14. 10.4049/jimmunol.149.11.347710.4049/jimmunol.149.11.3477 ↗
15. 10.1172/JCI11842010.1172/JCI118420 ↗
16. 10.4049/jimmunol.173.6.405810.4049/jimmunol.173.6.4058 ↗
17. 10.4049/jimmunol.130201210.4049/jimmunol.1302012 ↗
18. 10.4049/jimmunol.144.4.130410.4049/jimmunol.144.4.1304 ↗
19. 10.4049/jimmunol.155.6.316110.4049/jimmunol.155.6.3161 ↗
20. 10.1016/j.imlet.2010.07.00410.1016/j.imlet.2010.07.004 ↗
21. 10.1038/ncomms644410.1038/ncomms6444 ↗
22. 10.4049/jimmunol.178.10.621710.4049/jimmunol.178.10.6217 ↗
23. 10.1126/science.111894810.1126/science.1118948 ↗
24. 10.1016/j.ccell.2023.10.00710.1016/j.ccell.2023.10.007 ↗
25. 10.1038/icb.2008.8210.1038/icb.2008.82 ↗
26. 10.1126/scitranslmed.aaf941810.1126/scitranslmed.aaf9418 ↗
27. 10.1124/jpet.106.10905810.1124/jpet.106.109058 ↗
28. 10.1111/j.1600-065X.2010.00910.x10.1111/j.1600-065X.2010.00910.x ↗
29. 10.4049/jimmunol.080349710.4049/jimmunol.0803497 ↗
30. 10.1038/nrd290910.1038/nrd2909 ↗
31. 10.1200/JCO.2004.06.00310.1200/JCO.2004.06.003 ↗
32. 10.1172/JCI1564010.1172/JCI15640 ↗
33. 10.4049/jimmunol.176.8.457310.4049/jimmunol.176.8.4573 ↗
34. 10.1016/j.cell.2015.04.01610.1016/j.cell.2015.04.016 ↗
35. 10.1016/j.jhep.2013.05.00310.1016/j.jhep.2013.05.003 ↗
36. 10.1038/s41541-018-0095-z10.1038/s41541-018-0095-z ↗
37. 10.1016/j.vaccine.2009.10.04010.1016/j.vaccine.2009.10.040 ↗
38. 10.1186/s12865-016-0143-210.1186/s12865-016-0143-2 ↗
39. 10.1016/j.celrep.2021.10958710.1016/j.celrep.2021.109587 ↗
40. 10.1371/journal.pone.006098910.1371/journal.pone.0060989 ↗
41. 10.1038/nature0118810.1038/nature01188 ↗
42. 10.4049/jimmunol.120050110.4049/jimmunol.1200501 ↗
43. 10.1016/j.cels.2018.05.01810.1016/j.cels.2018.05.018 ↗
44. 10.15252/emmm.20211418210.15252/emmm.202114182 ↗
45. 10.1016/j.celrep.2023.11273410.1016/j.celrep.2023.112734 ↗
46. 10.1038/s41598-017-17255-810.1038/s41598-017-17255-8 ↗
47. 10.1073/pnas.080171710510.1073/pnas.0801717105 ↗
48. 10.1083/jcb.98.4.116310.1083/jcb.98.4.1163 ↗
49. 10.1091/mbc.e13-04-017410.1091/mbc.e13-04-0174 ↗
50. 10.1084/jem.2001109710.1084/jem.20011097 ↗
51. 10.1084/jem.189.2.37110.1084/jem.189.2.371 ↗
52. 10.1016/j.immuni.2012.09.01410.1016/j.immuni.2012.09.014 ↗
53. 10.1126/scitranslmed.300118010.1126/scitranslmed.3001180 ↗
54. 10.1016/j.immuni.2013.02.02310.1016/j.immuni.2013.02.023 ↗
55. 10.1016/j.vaccine.2015.02.03610.1016/j.vaccine.2015.02.036 ↗
56. 10.1111/j.1467-7652.2011.00593.x10.1111/j.1467-7652.2011.00593.x ↗
57. 10.1038/s41598-022-27279-410.1038/s41598-022-27279-4 ↗
58. 10.1242/jcs.0227510.1242/jcs.02275 ↗
59. 10.1016/j.jconrel.2022.04.03710.1016/j.jconrel.2022.04.037 ↗
60. 10.1002/adfm.20160365110.1002/adfm.201603651 ↗
61. 10.1038/nature0458610.1038/nature04586 ↗
62. 10.1126/science.117425110.1126/science.1174251 ↗
63. 10.1021/acsnano.9b0646610.1021/acsnano.9b06466 ↗
64. 10.1038/nature0801610.1038/nature08016 ↗
65. 10.1126/science.121408110.1126/science.1214081 ↗
66. 10.1016/j.xcrp.2022.10123710.1016/j.xcrp.2022.101237 ↗
67. 10.1002/adhm.20210184410.1002/adhm.202101844 ↗
68. 10.1038/s41565-020-0719-010.1038/s41565-020-0719-0 ↗
69. 10.1021/jacs.4c0277210.1021/jacs.4c02772 ↗
70. 10.1038/s41565-018-0336-310.1038/s41565-018-0336-3 ↗
71. 10.1038/s41467-020-18910-x10.1038/s41467-020-18910-x ↗
72. 10.1002/biot.20200031110.1002/biot.202000311 ↗
73. 10.1021/jacs.1c0229810.1021/jacs.1c02298 ↗
74. 10.1038/s41467-020-16949-410.1038/s41467-020-16949-4 ↗
75. 10.1002/jcb.2904310.1002/jcb.29043 ↗
76. 10.1073/pnas.100824810710.1073/pnas.1008248107 ↗
77. 10.1084/jem.142.6.152010.1084/jem.142.6.1520 ↗
78. 10.4049/jimmunol.144.1.37110.4049/jimmunol.144.1.371 ↗
79. 10.1128/CVI.00194-0910.1128/CVI.00194-09 ↗
80. 10.1016/S0161-5890(98)00069-810.1016/S0161-5890(98)00069-8 ↗
81. 10.1038/ncomms1565410.1038/ncomms15654 ↗
82. 10.1021/acsnano.5b0132610.1021/acsnano.5b01326 ↗
83. 10.1083/jcb.55.3.61610.1083/jcb.55.3.616 ↗
84. 10.1006/excr.1998.411010.1006/excr.1998.4110 ↗
85. 10.1038/s41565-023-01449-510.1038/s41565-023-01449-5 ↗
86. 10.1021/jacs.7b0902410.1021/jacs.7b09024 ↗
87. 10.1016/j.jconrel.2019.06.01910.1016/j.jconrel.2019.06.019 ↗
88. 10.1016/j.nano.2021.10238610.1016/j.nano.2021.102386 ↗
89. 10.1021/bc100242310.1021/bc1002423 ↗
90. 10.1002/adma.20200845710.1002/adma.202008457 ↗
91. 10.1016/S0168-3659(01)00412-610.1016/S0168-3659(01)00412-6 ↗
92. 10.1023/A:101896512122210.1023/A:1018965121222 ↗
93. 10.1038/nnano.2013.30910.1038/nnano.2013.309 ↗
94. 10.1091/mbc.e08-02-022310.1091/mbc.e08-02-0223 ↗
95. 10.1021/acs.nanolett.8b0066010.1021/acs.nanolett.8b00660 ↗
96. 10.1016/j.bpj.2013.07.03610.1016/j.bpj.2013.07.036 ↗
97. 10.1002/smll.20240023610.1002/smll.202400236 ↗
98. 10.1002/3527608761.ch210.1002/3527608761.ch2 ↗
99. 10.1021/ja01142a04510.1021/ja01142a045 ↗
100. 10.1016/S0022-1759(98)00071-410.1016/S0022-1759(98)00071-4 ↗